FTO-IN-6, identified by its CAS number 2968347-63-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in cancer treatment. As a small molecule inhibitor, it is designed to target specific proteins or pathways involved in tumor growth and proliferation. The compound's structure typically includes functional groups that enhance its binding affinity to biological targets, which is crucial for its efficacy. FTO-IN-6 is characterized by its ability to modulate gene expression through the inhibition of certain demethylases, thereby influencing RNA metabolism and cellular processes. Its pharmacokinetic properties, such as solubility, stability, and bioavailability, are essential for determining its therapeutic potential. Ongoing research aims to elucidate its mechanism of action, optimize its chemical properties, and evaluate its safety and effectiveness in preclinical and clinical settings. As with many investigational compounds, further studies are necessary to fully understand its characteristics and potential applications in oncology.

FTO-IN-6

2968347-63-7: FTO-IN-6, identified by its CAS number 2968347-63-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in cancer treatment. As a small molecule inhibitor, it is designed to target specific proteins or pathways involved in tumor growth and proliferation. The compound's structure typically includes functional groups that enhance its binding affinity to biological targets, which is crucial for its efficacy. FTO-IN-6 is characterized by its ability to modulate gene expression through the inhibition of certain demethylases, thereby influencing RNA metabolism and cellular processes. Its pharmacokinetic properties, such as solubility, stability, and bioavailability, are essential for determining its therapeutic potential. Ongoing research aims to elucidate its mechanism of action, optimize its chemical properties, and evaluate its safety and effectiveness in preclinical and clinical settings. As with many investigational compounds, further studies are necessary to fully understand its characteristics and potential applications in oncology.

<p>FTO-IN-6 is a selective inhibitor of fat mass and obesity associated protein (FTO).</p>

CAS 2968347-63-7

FTO-IN-6

FTO-IN-6

Ref: TM-T60994